The effects of family history and personal experiences of illness on the inclination to change health-related behaviour
Jazyk angličtina Země Česko Médium print
Typ dokumentu časopisecké články
PubMed
19418712
DOI
10.21101/cejph.a3506
Knihovny.cz E-zdroje
- MeSH
- chování snižující riziko * MeSH
- cvičení MeSH
- kardiovaskulární nemoci psychologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- obezita psychologie MeSH
- odvykání kouření MeSH
- průřezové studie MeSH
- průzkumy a dotazníky MeSH
- stupeň vzdělání MeSH
- zdravé chování * MeSH
- zdraví - znalosti, postoje, praxe * MeSH
- zdraví rodiny MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Polsko MeSH
- Švédsko MeSH
The aim of the present study was to examine how a personal experience of illness and a family history of cardiovascular disease (CVD), adjusted for sex, level of education and nationality, affect risk behaviour. Participants were 1,011 and 1,043, 50-year-old men and women from Sweden and Poland, respectively, who were recruited from a primary health care screening programme. Family history, personal experience of illness and risk behaviour (smoking and exercise habits, BMI level) were self-reported. The results showed that smoking behaviour was affected by a personal experience of illness but not by a family history of CVD. No effects of these variables were found on the remaining risk-related variables tested in this study. These results suggest that individuals with a personal experience of illness may be more inclined to change smoking behaviour than the average person. Smoking prevention strategies may therefore benefit from targeting this group in particular.
Zobrazit více v PubMed
Int J Clin Pharmacol Ther. 2004 Feb;42(2):103-9 PubMed
Dis Manag. 2007 Oct;10(5):273-84 PubMed
Z Kardiol. 2004 Jan;93(1):72-90 PubMed
Control Clin Trials. 2000 Oct;21(5 Suppl):184S-7S PubMed
JAMA. 1999 Jun 9;281(22):2075-6 PubMed
Eur Heart J. 2006 Oct;27(19):2285-93 PubMed
Cerebrovasc Dis. 2003;15(4):282-8 PubMed
Eur J Clin Pharmacol. 2005 Jan;60(11):797-805 PubMed
JAMA. 1998 Aug 19;280(7):623-9 PubMed
Eur Heart J. 2002 Dec;23(23):1809-40 PubMed
Int J Clin Pharmacol Ther. 2003 Feb;41(2):77-82 PubMed
Z Kardiol. 2004 Apr;93(4):324-41 PubMed
N Engl J Med. 2001 Aug 16;345(7):494-502 PubMed
Eur Heart J. 2001 Oct;22(19):1794-801 PubMed
Dtsch Med Wochenschr. 2007 Nov;132(45):2367-70 PubMed
Z Kardiol. 2001 Jun;90(6):394-400 PubMed
J Am Coll Cardiol. 2002 Oct 2;40(7):1366-74 PubMed
Eur J Clin Pharmacol. 2005 Jul;61(5-6):433-8 PubMed
Eur Heart J. 2005 Apr;26(8):804-47 PubMed
Gesundheitswesen. 1997 Apr;59(4):258-61 PubMed
Lancet. 2001 Mar 31;357(9261):995-1001 PubMed
